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Age is one of the most important risk factors when it comes to stroke risk prediction.
However, including age as a risk factor in a stroke prediction model can give rise to a
number of difficulties. Age often dominates the risk score, and also not all risk factors
contribute proportionally to stroke risk by age. In this study we investigate a number of
common stroke risk factors, using Framingham heart study data from the NHLBI Biologic
Specimen and Data Repository Information Coordinating Center to determine if they
appear to contribute proportionally by age to a stroke risk score. As we find evidence
that there is some non-proportionality by age, we then create a set of logistic regression
risk models that each predict the 5 year stroke risk for a different age group. The age
group models are shown to be better calibrated when compared to a model for all ages
that includes age as a risk factor. This suggests that to get better predictions for stroke
risk it may be necessary to consider alternative methods for including age in stroke risk
prediction models that account for the non-proportionality of the other risk factors as
age changes.
Keywords: stroke, predictive modeling, machine learning, epidemiology, risk

1. INTRODUCTION
Globally stroke is one of the leading causes of mortality. In the US the annual direct medical costs
for stroke in 2012 was 71.55 billion US dollars (1). This cost, however, only takes into account
the direct costs and does not consider years lost to work or other societal burdens that are caused
by stroke, so the actual cost is much higher. One way to reduce the overall burden of stroke on
society is to find better ways to prevent stroke. Currently, one of the methods used for stroke
prevention is to identify patients with a high risk of having a stroke based off of certain risk
factors. This identification is often done through risk prediction models, such as SCORE (2) and
the Framingham heart study model (3, 4). Once identified a patient can be advised to adjust their
behaviors or be treated with appropriate medications to lower their risk of having a stroke.
The risk factors used to predict stroke can either be modifiable or non-modifiable (5). One of
the most important non-modifiable risk factors is age, the older a person is the more likely they are
to have a stroke (6). Although its important to take age into consideration when predicting stroke
risk, it can also, lead to a number of complications. As age is non-modifiable, if an individuals stroke
risk is high solely because of their age, it can lead to unnecessary stress as they cannot change their
age. Conversely, having a low risk score due to age might make an individual complacent despite
having other risk factors for stroke that will lead to high risk as they age. Approximately two thirds

1

February 2022 | Volume 13 | Article 803749

Hunter and Kelleher

Age Specific Stroke Risk Models

In the following sections, we discuss the data set used for our
analysis, the modeling data sets we selected from the full data
set and finally our methods for analyzing the data and modeling
stroke risk.

complete lifestyle and medical history questionnaires at regular
intervals. The Framingham-Cohort data set recruited 5,209 men
and women, aged 28–62, between 1948 and 1952, and has data for
32 clinical exams per subject through 2018 (10). The Framingham
Offspring data set is made up of 5,124 men and women, between
the ages of 5 and 70, who were recruited as offspring of the
original Framingham cohort or spouses of offspring, and has
data from 9 clinical exams per subject through 2018 (11). The
Omni 1 cohort is made up of 507 men and women of AfricanAmerican, Hispanic, Asian, Indian, Pacific Islander, and Native
American origins, who were recruited in 1994 and were residents
of Framingham or the surrounding towns. There is data from the
first four clinical exams per subject from the Omni cohort (11).
The third generation cohort is made up of 4,095 men and women,
ages 19 plus with at least one parent in the Framingham Offspring
cohort, and has data from the first 2 clinical exams per subject
through 2018 (12). The New Offspring Cohort enrolled spouses
of Offspring participants who were not already enrolled and had
at least two biological children participating in the Generation
three cohort. The new offspring cohort recruited 103 men and
women (12). The Omni 2 cohort enrolled 410 participants who
were ethnically diverse compared to the other cohorts which are
predominately white. Some of the Omni 2 cohort are related to
those who participated in the Omni 1 cohort while others are
unrelated (12).1
As we are looking at short term risk, we do not look
longitudinally at an individual but instead break down the data
set into separate records for each clinical exam. This means that
the same person might appear in our data set more than once.
Across the cohorts there are 113,714 clinical exam records. To
look at short term ischemic stroke risk we created a flag for
clinical exams of individuals who suffered an ischemic stroke
within 5 years of that clinical exam. For the purpose of our
study we are only looking at the risk of ischemic stroke so we
do not consider anyone who has a hemorrhagic or unknown type
of stroke.
We remove any clinical exams from the data set where there
is missing data for any of the continuous risk factors we are
considering: systolic blood pressure, diastolic blood pressure and
total cholesterol. For BMI, if there is no value for BMI in a
given data collection year but a weight for that year we use the
height collected in the first data collection phase and calculate
the individual’s BMI with their height and current weight. Where
there is missing data for our categorical variables as most
categorical variables are to identify a condition or treatment we
consider a missing variable equivalent to not having the condition
or not smoking.

2.1. Data

2.1.1. Modeling Data Set: Age Groups

We use data from the Framingham Heart Study combining the
Framingham-Cohort, Offspring, Third Generation, OMNI 2, and
New Offspring cohorts from the NHLBI. The Framingham Heart
Study is a longitudinal study that began in 1948 that sampled
both men and women in Framingham, Massachusetts with the
goal of studying the incidence and prevalence of cardiovascular
disease and its risk factors over time. Participants recruited into
the Framingham Heart Study undergo clinical examinations and

In order to assess the non-proportionality of risk factors by age,
we separate the data set into four data sets based on age: less than
50, 50–59, 60–69, and 70 plus. As the data is greatly unbalanced
we select two controls for each stroke. The controls are matched
on age and cardiovascular disease status and are selected from the

of US adults who have low short term stroke risk have been shown
to have a high lifetime risk (7). Additionally, age is such a strong
predictor of stroke, if it is included as a risk factor in a model it
can sometimes dominate the risk score and thereby can lead to
under prediction in the younger age groups and over-prediction
in the older age groups (8).
When age is considered as a risk factor, this assumes that
the contribution of the other risk factors in the model are
proportional by age, in other words that their contribution to risk
does not change with age. For example, under the assumption of
proportionality by age, having diabetes as a 45 year old produces
the same level of stroke risk as having diabetes at 80. This
assumption is particularly important when looking at short term
risk where individuals are likely to stay in an age group for the
whole prediction period. This may be a problem as it is likely
that risk factors differ between the young and old (5). Another
example, of why the assumption of proportionality by age does
not hold is the impact of age on sex as a risk factor. In the
study by (9), they showed that younger women have lower short
term risk of a stroke than men but as they age, this switches
and women have higher short term risk than men. Thus, the
contribution of sex as a risk factor should be different based on
an individual’s age.
In this paper we aim to answer two questions: (1) is there
evidence that the contribution of stroke risk factors to an
individual’s 5 year stroke risk are non-proportional by age, and
(2) if there is evidence that risk factors are non-proportional by
age, how can we create a risk model to better capture this nonproportionality when predicting an individual’s risk of stroke.
To answer these questions we investigate if there is a difference
in risk factor contribution to stroke risk by age to short term
stroke risk, and to account for any difference we propose creating
a stroke risk prediction model that is made up of four separate
models, each covering a different age group. We first discuss
the data used, then we present a statistical analysis of the data
looking specifically at risk factors by age group. Finally we create
multi-variable logistic regression stroke risk prediction models,
comparing a model created using the full age range with a set of
age specific models created by breaking the data set into different
age groups.

2. MATERIALS AND METHODS

Frontiers in Neurology | www.frontiersin.org

1 For more information on the data and data collection, see https://biolincc.nhlbi.
nih.gov/home/.
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for continuous or Pearson’s Chi-squared for categorical factors),
if the p-value for a test is significant than there is a statistical
difference between the distribution of the risk factor across the
age groups for which the test was run.
For the analysis examining risk factors across age groups we
restrict the population of each age group to only those who
are identified as suffering a stroke within 5 years of a clinical
examination that was carried out when they were in that age
group. This is done for two reasons. The first is that it will identify
only the risk factors whose distributions differ across age groups
for the population we are looking to predict, those who have had
a stroke. The second reason is to meet statistical assumptions.
One of the assumptions of the Pearson’s Chi-squared test is that a
single individual can only contribute data once to the data being
analyzed (14). In our sampling method, we allow for the same
individual to be included multiple times, once for each clinical
exam. However, as only the first stroke is recorded in the data set
an individual can only appear once in the stroke population of
our data.
Once we defined a data set for each age group composed
of those who suffered a stroke within 5 years of a clinical
examination within the age group, we then take each risk factor
in turn and run a statistical test on this data set to assess
whether the variation of that risk factor across the age groups
was likely caused by random variation or represents a statistically
significant variation. If the p-value returned by the statistical test
for a given risk factor is less that 0.05 we will take this to signify
that there is a statistically significant variation in that risk factor
across age groups among those who have had a stroke. Such a
finding would provide evidence that the contribution of that risk
factor to stroke risk is non-proportional by age and this would
justify investigating further the differences in risk factors by age
and signal whether there is likely non-proportionality in risk
factors by age.
After looking across age groups we then look within age
groups comparing those who have had a stroke within 5 years
of a clinical examination carried out when they were in that age
group and those who did not have a stroke within 5 years of their
clinical examination within the age group. In this analysis we
assess: (i) which risk factors might make important contributions
to the risk for an individual in a given age group, and (ii) if the
risk factors that might be important vary across age groups. We
carry out a separate statistical test for each risk factor in each
age group to determine if the variation of a risk factor between
those within the age group who have had a stroke and those
within the age group who did not have a stroke is statistically
significant. If there is a statistically significant difference in the
distribution of a risk factor between those who have had a
stroke and those who have not had a stroke then the risk factor
may be important in calculating stroke risk for people within
that age group. This in itself would be an important finding.
Furthermore, with respect to our main research question (1),
if we observe that for a given risk factor there is a statistically
significant variation of its occurrence between the stroke and
non-stroke population in some age groups but not in others this
would provide further evidence that the contribution of factors
to stroke risk is non-proportional by age. For the analysis of risk

set of clinical exams where the individual examined did not suffer
a stroke within 5 years of the exam. We do not control for those
who have had a stroke outside of our time window, thus a clinical
exam in the controls might be for an individual who suffered
a stroke 6 years after the clinical exam or 20 years after the
examination, meaning the individual’s overall stroke risk might
still be higher than the control clinical exams for individuals who
have not had a stroke during their lifetime. This down sampling
of non-strokes resulted in a data set of 113,714 clinical exams,
one third of which have had a stroke within 5 years. Note that,
the 1:2 (stroke:non-stroke) ratio is maintained across the four age
groups. When modeling on all age groups with age as a risk factor
we combine the four age groups data sets to create a single data
set that contains all ages.

2.2. Statistical Analyses and Modeling
The first part of our study is an analysis that assesses whether
there is a statistically significant difference in the data for risk
factors by age group. This analysis is done to determine if
risk factors are non-proportional by age. This statistical analysis
is itself composed of three parts. First, we present descriptive
statistics of the full data set and the modeling data sets. We then
examine variation in each risk factor across age groups where for
each age group cohort we only consider those people who had a
stroke, and finally we examine risk factors variation within each
age-group between those who have had a stroke and those who
have not.
Looking at risk factors across age groups we aim to determine
if we see a difference in the distributions of a given risk score
across the age groups. Different distributions would suggest that a
risk score might contribute non-proportionally to an individual’s
risk score by age. There are two data type for the possible risk
factors in the model: continuous and categorical. As such there
are different statistical tests that need to be considered for each
type of data. For each of the continuous risk factors (systolic
blood pressure, diastolic blood pressure, total cholesterol, BMI,
and cigarettes per day) we use a Kruskal-Wallis test to assess the
variation of the risk factor across age groups. The Kruskal-Wallis
test is a non-parametric test that determines if the medians from
more than two independent groups are the same (13). If the test
is significant (p < 0.05), than the distribution of the risk factor
is not the same for all age groups. Note that for the cigarettes
per day risk factor we consider two encodings of the variable:
one for all individuals and one for only smokers. We do this
because when all individuals are included in the statistical tests
for the average number of cigarettes smoked per day, all of those
individuals who do not smoke will have a value of 0. This could
bias the results, thus we also look at the distribution of cigarettes
per day in only those who smoke to determine if there is a
difference in the number of cigarettes smoked for those who do
smoke and have had a stroke vs. those who do smoke and have
not had a stroke. For the categorical variables (sex, smoking,
atrial fibrillation, diabetes, high blood pressure treatment) we
use Pearson’s Chi-squared test, which is a non-parametric test
that determines if there is a difference in the occurrence of a
dependent variable based on an independent variable (14). As
noted above, regardless of the statistical test run (Kruskal-Wallis

Frontiers in Neurology | www.frontiersin.org
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is a measure of the difference between the estimated and the true
risk and gives an idea of how the model will fit to a different
data set (16). Looking at calibration, in addition to the more
commonly used discrimination measures, is important as it can
help to identify models that on the whole discriminate well but
that do not predict well for certain groups, for example older or
younger patients (16).
To calculate the discrimination and calibration measures we
use k-fold cross validation with 10-folds to estimate average of
each metric we describe below. We look at a number of different
measures for discrimination, focusing on the F1 measure, the
AUC (area under the receiver operating characteristic curve), and
the accuracy of the model. The F1 measure is the harmonic mean
of precision (how often a model makes a positive prediction that
is true) and recall (the true positive rate). The AUC plots the
true positive rate against the false positive rate as the prediction
threshold of a model and ranges from 0 to 1. Accuracy or
the classification accuracy is the portion of predictions that are
correct (17). For calibration we use the Spiegelhalter’s p-value and
the Hosmer-Lemeshow test designed to predict goodness of fit.
The Spiegelhalter’s Z-test separates the calibration aspects out of
the Brier Score2 (18). If the p-value for the test is significant this
suggests that the model is not well-calibrated (16). The HosmerLemeshow test measures calibration by looking at goodness of
fit. The test divides the data into a set number of groups and
the test statistics is calculated by comparing the number of
events in each group with the expected number of events in
each group determined using the predicted probabilities from the
model. Similar to the Spiegelhalter’s p-value, if the p-value for the
Hosmer-Lemeshow test is significant the model is assumed to be
not well-calibrated (18).
As a final analysis of the models we look at the ranking of
importance of features in each multi-variable model (the single
model including age and the ensemble of age cohort specific
models) to determine if this changes across the different age
models. This allows us to determine which risk factors are the
most important in each model. A difference in the order of
the importance of features across the different age models, will
provide additional evidence that contribution of risk factors vary
by age group and thus there might be non-proportionality of
risk factors by age. To calculate feature importance we use the
varImp function from the Caret package in R that calculates
feature importance for a linear model, such as logistic regression,
by comparing the absolute values of the t-statistic for each model
parameter (19). The contribution of each feature to the logistic
regression model is calculated using the absolute value of the
t-statistic for each feature.

factors within age groups, again, we have two types of variables
continuous and categorical. For the continuous variables we use
a Wilcoxcon Rank Sum test which is used to test if two samples
are likely derived from the same population (15). Similar to the
across group analysis, for the analysis of the categorical variables
within groups we use a Pearson’s Chi-squared test. As before,
irrespective of the type of test run, if the statistical test run for
a given risk factor within an age group returns a significant pvalue this would signify that there is a difference between the
distribution of that risk factor for those who have had a stroke
and those who have not within that age group.
After the statistical tests are completed, the second part of our
study focuses on modeling and aims to answer the question how
can we create a risk model that predicts an individual’s stroke
risk to better capture this non-proportionality in risk factors
by age. In our risk analysis we use logistic regression models.
While there are other types of models that are utilized for stroke
risk prediction, for example survival analysis, we choose logistic
regression as in our analysis we focus on whether a stroke has
occurred within a time window (rather than when in that time
window a stroke occurs). A logistic regression risk model takes
one or more risk factors or features from an individual and
predicts that individual’s risk of an event occurring within a
predefined time-window, in this case stroke within the next 5
years. We run a multi-variable logistic regression and compare
a single multi-variable regression that includes age as a risk
factor against a set of multi-variable models that do not explicitly
consider age as a factor but where each model in the set is fit
to a specific age cohort and taken together the set of age cohort
specific models covers the age spectrum. For any given individual
their stroke risk is predicted using the model trained on the age
cohort that corresponds with the individual’s age. The other risk
factors we consider in the models are sex, systolic blood pressure,
diastolic blood pressure, BMI, average cigarettes per day, atrial
fibrillation, and diabetes. For risk factors that are continuous:
age, BMI, and systolic and diastolic blood pressure we scale the
variables by standardizing (subtracting the mean and dividing
by the standard deviation). This does not change the predictions
of the model but allows us to interpret the coefficients of all the
variables on a similar scale.
In comparing the multi-variable models (the single model
including age and the ensemble of age cohort specific models)
we look at the changes in coefficients, the predictive ability of
the models using discrimination measures and the calibration of
the models. Each of our logistic regression models are designed
and trained to predict a personalized stroke risk score for an
individual based on their values for the risk factors the model
considers (e.g., sex, smoking, systolic blood pressure, and so on).
Although the models function by making predictions on a per
individual basis, they are evaluated based on their performance
across a group of individuals. In other words, model performance
is reported using aggregate statistics calculated across the model’s
performance on a number of individual cases (e.g., the average
model accuracy across a sample of individuals that were not
included in the dataset the model was fitted to during training).
While discrimination gives a measure of the predictive power of a
model or how well the model is able to fit to the data, calibration

Frontiers in Neurology | www.frontiersin.org

3. RESULTS
3.1. Data Description
Before performing any statistical analyses we first look at
descriptive statistics of the data set. The following sections
2 The Brier Score is the mean squared error between the outcome and the estimated
probabilities.
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TABLE 2 | Distributions of continuous stroke risk factors.

TABLE 1 | Ischemic strokes by age group.
Total
Stroke in 5 years

Less than 50

50–59

60–69

70 plus

Minimum

Median

Mean

Maximum

Missing

1417

2,114

106

277

586

1,145

Systolic blood pressure

No stroke in 5 years

111,600

36,709

28,510

24,540

21,841

Total

52

130.0

134.1

390.0

Lifetime stroke

14,983

3,821

4,066

3,929

3,167

Stroke

79.0

150.0

155.1

390.0

70

No lifetime stroke

98,731

32,994

24,721

21,197

19,819

No stroke

52.0

130.0

133.8

383.0

1347
354

Diastolic blood pressure

present these descriptive statistics for the full data set used and
the modeling data sets.

25.0

79.0

78.9

163.0

Stroke

38.0

80.0

80.7

148.0

14

No stroke

25.0

79.0

78.9

164.0

340

Total

12.0

25.8

26.4

66.6

1437

Stroke

14.0

26.4

26.9

53.6

55

No stroke

12.0

25.8

26.4

66.6

1382
27906

BMI

3.1.1. Full Data Set
Table 1 gives the number of strokes that occur within 5 years of
a clinical exam for the whole data set and by age groups. We also
include the counts of those who had a stroke at any point in their
lifetime and number of clinical exam records without a stroke
in 5 years or in the patient’s lifetime. From the table, we observe
that there are more lifetime strokes than strokes within 5 years
of a clinical exam. The difference between the value for lifetime
strokes (14,983 in the whole data set) and strokes within 5 years
(2,114 in the whole data set) are those strokes that occur outside
of a 5 year window from a given clinical exam and these strokes
are not used in our analysis.
Although all do not end up in our final models, we consider
the following 10 risk factors: Systolic Blood Pressure, Diastolic
Blood Pressure, Total Cholesterol, BMI, Sex, Smoking, Average
cigarettes per day, Atrial Fibrillation, Diabetes, High blood
pressure treatment.
Table 2 shows the distributions of the continuous risk factors
across the data set for the whole data set, those who have had
a stroke in 5 years and those who have not had a stroke. In
the table, we show the minimum, median, mean, and maximum
values and the number of missing values for each risk factor.
From the table, we can see that the distributions from those who
have had a stroke in 5 years and those who have not had a stroke
in 5 years appear to be different across the risk factors, with the
distributions for those who have not had a stroke similar to the
distribution for the whole data set. Most noticeably is the large
difference between the median and mean systolic blood pressure
in the stroke and no stroke groups.
Table 3 shows the distribution of the categorical variables
across the data and for each variable level counts for those who
have had a stroke in 5 years and those who have not had a stroke,
the percent of those with the level of the variable that had a
stroke and counts of missing variables. From the table, we can
see that while strokes seem to be evenly distributed across males
and females and those who smoke, the percentage of those with
atrial fibrillation, diabetes or high blood pressure treatment that
have had a stroke in 5 years is much higher than the percentage
of those who do not have the risk factor and have a stroke. This
suggests that these variables might be significant risk factors.

Total cholesterol
Total

27.0

212.0

214.4

1124.0

Stroke

49.0

174.0

215.1

608.0

879

No stroke

27.0

212.0

214.4

1124.0

27027
13,019

Cigarettes per day (only smokers)
Total

0

20.0

19.4

100

Stroke

0

20.0

20.1

60

175

No stroke

0

20

19.4

100

12,844

TABLE 3 | Distributions of categorical stroke risk factors.
Stroke

No stroke

Stroke percent

Sex
Male

958

48,936

1.9

Female

1,156

62,664

1.8

Missing

0

0

Yes

470

27,880

1.7

No

1,470

70,913

2.0

174

12,807

Smoking

Missing
Atrial fibrillation
Yes

431

3,578

10.8

No

1,683

108,022

2.0

0

0

Missing
Diabetes
Yes

245

4,261

5.4

No

1,856

107,023

1.5

13

316

Missing

High blood pressure treatment
Yes

901

21,459

4.0

No

1,041

74,027

1.4

172

16,114

Missing

shows by age group the median value for each continuous risk
factor for those who have had a stroke in 5 years and those who
have not had a stroke in 5 years. The table shows that there are
some variables whose medians do not seem to change across
age groups such as BMI or cigarettes per day. However, there

3.1.2. Modeling Data Set
After creating the age group data sets for modeling we look at
the distributions of variables across the different ages. Table 4

Frontiers in Neurology | www.frontiersin.org
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TABLE 6 | Pearson’s Chi-squared p-value for categorical variables and
Kruskal–Wallis p-value for continuous variables by age group.

TABLE 4 | Median value of continuous variables by age group and stroke or
non-stroke outcome.
Less than 50

50–59

60–69

70 plus

P-value

Systolic blood pressure

Sex

1.936e-06

Total

127.0

137.0

141.0

148.0

Smoking

<2.2e-16

Stroke

135.5

145.0

149.0

153.0

Atrial fibrillation

<2.2e-16

No stroke

124.0

133.0

138.0

145.0

Diabetes

1.536e-07

Diastolic blood pressure

High blood pressure treatment

<2.2e-16

Systolic blood pressure

7.619e-09

Total

82.0

84.0

80.00

73

Stroke

84.0

90.0

84.00

75.00

Diastolic blood pressure

<2.2e-16

No stroke

81.0

82.0

80.00

72.00

Total cholesterol

< 2.2e-16

Total

26.1

26.57

26.71

26.28

Cigarettes per day (all individuals)

< 2.2e-16

Stroke

27.2

27.57

27.06

26.43

Cigarettes per day (only smokers)

0.1071

No stroke

25.6

26.20

26.55

26.16

BMI

BMI

0.0005

Total cholesterol
Total

222.5

234.0

224.0

188.0

Stroke

247.0

238.0

227.0

191.0

No stroke

213.0

233.5

222.0

186.0

group. This signifies that there might be a difference in risk
factors by age group worth investigating.

Cigarettes per day (only smokers)
Total

20.0

20.0

20.00

15.00

Stroke

21.7

20.00

20.00

20.00

3.2. Statistical Analysis to Test
Non-proportionality of Risk Factors

No stroke

23.7

20.00

20.00

12.00

3.2.1. Comparing Risk Factors Across Age Groups
We first investigate if the distribution of risk factors varies across
age groups to determine if the risk factors that contribute to an
individual’s risk of stroke changes across age groups.
Table 6 shows the p-values for the Chi-Squared tests
(categorical variables) and Kruskal-Wallis tests (continuous
variables) looking at the differences in risk factors across age
groups in individuals who have a stroke within 5 years of a clinical
examination. For the categorical variables (sex, smoking, atrial
fibrillation, diabetes, and high blood pressure treatment) all of
the p-values are much less than 0.05 showing that there is likely
a difference in the distribution of risk factors in those who have
had a stroke across age groups.
All variables except for cigarettes per day in the smokers have
at least one age group with a distinct distribution of the risk factor
in those who have had a stroke. For smokers who have had a
stroke the p-value is 0.11 which although is not significant at
the 10% level is still small and could be considered as potentially
showing differences in risk factor distributions across age groups.
The analysis in this section provides evidence that for each risk
factor we might see some differences in the contribution to risk
of stroke by age.

TABLE 5 | Percent of clinical exams with an ischemic stroke in 5 years for the
categorical risk factors.
Less than 50

50–59

60–69

70 plus

Sex
Male

31.1

32.8

38.2

38.7

Female

36.0

34.0

36.3

35.3

Yes

31.0

27.8

44.6

41.0

No

35.4

37.6

34.5

36.8

Yes

43.8

65.6

78.5

86.1

No

32.6

31.9

34.5

30.6

Yes

22.2

50.6

58.7

39.9

No

33.8

31.3

34.3

37.0

Smoking

Atrial fibrillation

Diabetes

Blood pressure treatment
Yes

47.6

37.2

40.8

38.5

No

32.0

32.5

35.3

36.0

3.2.2. Comparing Risk Factors Within Age Groups
Our second statistical analysis of risk factors is carried out
within each age group to identify risk factors that have different
distributions between those who have had a stroke and those who
have not had a stroke.
Table 7 shows the p-values for the Chi-Squared tests
on the categorical variables (sex, smoking, atrial fibrillation,
and diabetes) within each age group. From the p-values
we observe that we do get some difference in significance
across the groups. Most notably we see no p-values that
would be considered significant in the categorical variables

are some variables, systolic blood pressure, and total cholesterol
where the medians appear to change both by age and between the
stroke and non-stroke group.
Table 5 shows the percent of clinical exams where the
individual had a stroke in 5 years in each of the categorical
variable categories. From the table, it can be seen that the
percentage of individuals who have had a stroke in 5 years and
who smoke, have atrial fibrillation or diabetes changes with age
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TABLE 8 | Coefficients for the multi-variable logistic regression model including
age as a risk factor (*indicates a scaled variable).

TABLE 7 | Pearson’s Chi-squared p-value for categorical variables and Wilcoxon
rank sum p-value for continuous variables by age group (*indicates simulated
p-value due to small sample sizes).

Coefficient

P-value

−0.989

<2e-16

Less than 50

50–59

60–69

70 plus

Sex

0.497

0.777

0.441

0.058

Sex

0.07

0.29

Smoking

0.557

0.003

0.0002

0.136

Systolic blood pressure*

0.16

3.8e-5
< 2e-16

Intercept

Atrial fibrillation

0.522

0.0002

<2.2e-16

<2.2e-16

Diastolic blood pressure*

0.35

Diabetes

0.717*

0.0008

1.75e-11

0.345

BMI*

0.08

0.016

High blood pressure
treatment

0.226

0.356

0.03

0.163

Cigarettes smoked per day

0.02

3.5e-8

Atrial fibrillation

2.47

< 2e-16

Diabetes

0.59

1.6e-8

Age*

0.18

2.8e-5

Systolic blood pressure

1.19e-05

4.407e-11 < 2.2e-16 9.492e-10

Diastolic blood pressure

0.003

7.041e-11 5.162e-13 1.534e-09

Total cholesterol

0.003

0.098

BMI

0.025

Cigarettes per day (all
individuals)

0.317

Cigarettes per day (only
smokers)

0.340

0.016

0.118

2.934e-05

0.150

0.058

0.003

1.61e-05

0.067

0.874

0.004

0.0001

small enough to investigate the difference in BMI between
the groups.
For the cigarettes per day variable, it appears that in the 50–
59 age group whether someone smokes might have an impact
on their risk of stroke but the number of cigarettes that the
individual smokes might not be as important. In both the 60–
69 age group and the 70 plus age group, the differences in
the distributions of cigarettes smoked per day are significant
both for only smokers and when smokers and non-smokers are
considered. This might mean that not only does smoking have
an impact on an individual’s stroke risk but that the number of
cigarettes an individual in these age groups smokes might also
impact an individual’s stroke risk.

for the less than 50 age group. This is likely due to small
sample sizes.
In the other three age groups we see that there is a significant
difference in the distributions of those who have atrial fibrillation
and a stroke in 5 years vs. those who have not had a stroke across
the three groups. Diabetes appears to only have a significant
difference in the distribution between those who have had a
stroke and those who have not had a stroke in the 50–59 age
group and the 60–69 age group. Similarly, the difference in
smoking between those who have and had not had a stroke is
only significant at the 5% level in the two middle age groups.
However, the p-value in the 70 plus group for smoking is 0.14
which although not significant at the 10% level is small enough
that it should be considered as a factor that might impact the
risk of stroke. The only age group where the difference in the
distribution of sex between those who have and have not had a
stroke is significant is in the 70 plus age group and the difference
in the distribution for high blood pressure treatment is only
significant in the 60–69 age group.
In Table 7, we also present the results of our statistical analysis
of the differences in the distributions of the continuous risk
factors for those who have had a stroke within 5 years of a
clinical exam and those who have not had a stroke by each age
group. From the table, we can see that for most of the continuous
variables we see differences in the distributions between those
who have had a stroke and those who have not had a stroke. For
systolic blood pressure and diastolic blood pressure all four age
groups have significant differences. Looking at total cholesterol,
the three youngest age groups have p-values that are significant
at least a 10% level and the 70 plus age group has a p-value
that is 0.12 which is close to being significant at the 10% level
and thus could be considered to have an impact on the risk
of stroke. Similarly, for BMI the only age group that does not
have a p-value significant at the 5 or 10% level is 60–69 and
this group has a p-value of 0.15 which could still be considered
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3.3. Multi-Variable Logistic Regression
In the previous section, we found through statistical analysis
that there is evidence that the contribution of risk factors to
an individual’s stroke risk might be non-proportional by age. In
this section we use multi-variable logistic regression models to
develop a method to predict stroke risk for different age groups
taking the non-proportionality into account.

3.3.1. Model With Age as a Factor
Table 8 presents the coefficient for the multi-variable logistic
regression model that includes age as a risk factor.

3.3.1.1. Discrimination
To evaluate the model we look at both discrimination measures
and calibration measures. Table 9 shows the discrimination
measures when tested on all age groups together and on
individual age groups. As the all ages measures are calculated
using a 10-fold cross validation the standard deviations for the
measures across the folds are given in parentheses in the table.
We see that model performs relatively well with an AUC of 0.69
and accuracy of 0.7 for all ages.
To break the discrimination metrics down further we look at
how well the model predicts for individual age groups, by finding
the metrics for the individual age group data sets. While the
model seems to predict reasonably well for the older age groups,
the AUC, F1 measure, and accuracy drop considerably for the
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TABLE 10 | Coefficients for the age group specific logistic regression models
(*indicates a scaled variable).

TABLE 9 | Discrimination and calibration metrics when the model is tested on all
ages and by age group.
All ages

less than 50

50-59

60-69

Less than 50

70 plus

AUC

0.69 (0.03)

0.52

0.64

0.69

0.69

F1

0.42 (0.03)

0.31

0.43

0.37

0.49

Accuracy

0.70 (0.70)

0.64

0.66

0.69

0.73

Hosmer and
Lemeshow test

0.26 (7)

3.4e-5

0.03

0.44

0.12

Spiegelhalter’s test

0.54 (9)

Intercept
Sex
Systolic blood pressure*

0.002

0.09

0.24

0.38
Diastolic blood pressure*
BMI*

model when it is tested on the less than 50 age group and we also
observe a drop in the AUC when tested on the 50–59 age group.

Cigarettes smoked per day

3.3.1.2. Calibration

Atrial fibrillation

Table 9 also shows the p-values for the Hosmer and Lemewshow
goodness of fit test and Spiegelhalter’s Z-test. As we do a 10fold cross validation the p-values presented in the table are the
average p-value across the 10-folds and the number of folds
where the p-values are not significant is included in brackets.
The table also includes the p-values for the individual age groups.
For the all ages data set, both p-values are not significant, which
suggests that on the whole the model might be well-calibrated.
We also include the number of folds where the p-values were not
significant, and can see that for 7 out of 10-folds the HosmerLemeshow test suggests good calibration and for 9 out of 10-folds
the Speigelhalter’s Z-test suggests good calibration.
From Table 9, we also can see that while the model appears
to be well-calibrated in the older age groups it is not wellcalibrated in the younger age groups. Combined with the under
discrimination measures, the model trained on data across all
ages does not predict well, nor is it well-calibrated, for the
younger age groups.

Diabetes

60–69

70 plus

−0.87

−1.05

−0.95

−0.95

0.0009

3.4e-11

< 2e-16

< 2e-16
0.12

0.05

0.14

−0.15

0.87

0.48

0.24

0.20

0.57

0.20

0.31

0.15

0.04

0.17

0.0007

0.0008

0.09

0.42

0.24

0.25

0.71

0.006

0.009

1.12e-07

0.21

0.17

0.02

0.05

0.24

0.07

0.76

0.28

0.003

−0.007

0.03

0.02

0.77

0.35

1.48e-07

0.0003

1.18

1.78

2.28

2.68

0.07

0.0001

7.00e-16

< 2e-16

−0.42

1.04

1.12

0.21

0.64

0.0004

1.43e-09

0.17

TABLE 11 | Discrimination and calibration metrics for each age model.
Less than 50

50–59

60–69

70 plus
0.70 (0.03)

AUC

0.67 (0.16)

0.70 (0.05)

0.72 (0.03)

F1

0.22 (0.16)

0.41 (0.09)

0.47(0.06)

0.44(0.04)

Accuracy

0.70 (0.10)

0.71 (0.05)

0.68 (0.04)

0.71(0.02)

Hosmer and
Lemeshow test

0.23 (7)

0.34 (9)

0.32 (8)

0.35 (10)

Spiegelhalter’s test

0.34 (7)

0.52 (9)

0.44 (7)

0.58 (10)

significant in the middle age groups, but not in the oldest and
youngest age groups. BMI is only significant in the 50–59 age
group which is also the only age group (in this case at the 10%
level) where systolic blood pressure is not significant.

3.3.2. Separate Risk Models by Age Group
We then fit separate multi-variable logistic regression models
by age group. These models have the same risk factors that
are included in the model trained on all age groups with the
exception of age.
Looking at the coefficients and the statistical significance of
the coefficients in Table 10 we observe some interesting patterns.
We see the coefficient for systolic blood pressure tends to
decrease in size as age increases going from 0.57 in the less than
50 age group to 0.15 in the 70 plus age group. Diastolic blood
pressure increases from a non-significant coefficient of 0.09 in the
less than 50 age group to 0.25 in the 70 plus age group, with the
highest magnitude of the coefficient in the 50–59 age group. We
also see other increases in magnitudes in the coefficient for atrial
fibrillation, from 1.18 in the less than 50 group to 2.68 in the 70
plus group.
Besides changes in magnitudes we also see changes in
significance of coefficients between age models for the same
variables. The number of cigarettes smoked per day is significant
in the older age groups, 60–69 and 70 plus, but not for
the younger age groups, less than 50 and 50–59. Diabetes is

Frontiers in Neurology | www.frontiersin.org

50–59

3.3.2.1. Discrimination
We evaluate the age models using the same methodology we
applied to evaluate the model trained on all ages, looking
at both discrimination and calibration. Table 11 shows the
discrimination results presenting the AUC, F1 measure, and
accuracy for each model from a 10-fold cross validation and
the standard deviation for each measure in parentheses. We see
higher AUCs for all age groups compared to the single all ages
model with age as a risk factor and higher accuracy for the two
younger age groups. While the F1 measure drops in a few of the
age groups, the higher AUC might suggest that a change in the
prediction threshold may lead to better predictions.

3.3.2.2. Calibration
We also look at the calibration of the models. Table 11 also shows
the average p-value for the Hosmer and Lemeshow test, and the
average p-value for the Spiegelhalter’s t-test across the 10-folds
of model validation. We also include the number of folds that

8

February 2022 | Volume 13 | Article 803749

Hunter and Kelleher

Age Specific Stroke Risk Models

cigarettes per day and sex are the same for the under 50 and 50–59
age group and then change in importance for the 60–69 age group
but are the same between 60–69 and 70 plus. This might indicate
that there is a biological change between the 50–59 age group and
the 60–69 age group that leads to this difference in risk factor
importance.These changes are showing that features contribute
differently to the risk of each age group, further supporting the
needs for separate models by age group.

result in a “well-calibrated” model based on the Hosmer and
Lemeshow test and then again based off of the Spiegelhalter’s test
in parentheses.
None of the p-values in the table are significant suggesting
all four age models are well-calibrated. For both tests the 70
plus group was well-calibrated in all 10-folds, the 50–59 group
was well-calibrated in 9-folds and the less than 50 group in
7-folds. The 60–69 age group was well-calibrated based on
the Hosmer Lemeshow test in 8-folds and 7 based on the
Spiegelhalter’s test. Compared to the p-values in Table 9, we get
better calibration when modeling by age group especially in the
younger age groups.

4. DISCUSSION
Age is a key factor in an individual’s stroke risk with the
probability of having a stroke increasing with age. However,
there are other risk factors that are important in determining
the risk of stroke by age and if age is considered as a risk factor
in a model we have shown that the model may neglect the
contribution of these other factors. Additionally, the importance
of risk factors and contributions of different risk factors to an
individual’s risk changes with age. To account for the differences
in importance and contribution by age while still accounting for
the contribution of age we have created a set of models that
predict individual risk of stroke by age group. We have shown
that when looking at both discrimination and calibration metrics,
the age models are able to predict better and are better calibrated,
particularly in the younger age groups. While we do not see a
huge difference in the predictions for the 60–69 group and the 70
plus group, the increase in prediction, accuracy, and calibration
for the less than 50 and 50–59 group may help to identify younger
individuals with a high risk of stroke who may not be identified
using a traditional stroke risk prediction model.
The age models allow us to look at risk factors and their
changing contribution and difference in importance by age.
Although stroke is often seen as a health event, there are a
number of processes in the etiology that have lead up to that
event (20). Identifying the risk factors and interactions between
risk factors that change in importance between age groups cannot
only provide us with a better short term risk prediction but may
help to identify those who might have a high long term risk
despite a low short term risk because of the impact of a risk
factor over a long period of time. For example, while diabetes
is not seen as an important risk factor in those less than 50 it
becomes more important in the older age group and while a 45

3.3.2.3. Feature Importance
While we see that coefficient size and significance of the
coefficients change between age groups with some patterns
forming, to further look at the differences in risk factors between
age groups we look at the feature importance ranking for each of
the age models.
Figure 1 is a sankey diagram showing how the features
change in importance across the age group models. Each column
represents a different age model and each row in the column
represents a feature with the top row being the most important
feature. Following the colored links through the diagram shows
how the feature importance changes between models. Although
we see some features that have high importance across all age
models, such as atrial fibrillation, we also see some changes
in importance. For example, while BMI is the 3rd and 4th
most important feature in the less than 50 and 50–59 group
respectively it drops to the 7th for the two older age groups.
We also see that diabetes is more important in the middle two
age groups compared to the older and younger groups, and the
average number of cigarettes per day is more important in the two
older age groups than the younger two age groups.Interestingly,
the importance of systolic blood pressure and diastolic blood
pressure appear to change with age. While systolic blood pressure
is more important in the under 50 and 60–69 age group, diastolic
blood pressure is more important in the 50–59 and 70 plus age
group. In the figure, we can also see where there are changes in
the rank of important features moving between age groups which
might give an indication of where the interactions of risk factors
and age might change. For example, the rank of importance of

FIGURE 1 | Sankey diagram showing the change in feature importance ranking by age group.
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risk models by age group appears to produce models that are
better calibrated, the method has the limitation of reducing the
amount of data used to train each model. If the sample size is
already small breaking it into age groups could result in sample
sizes too small to be confident in any effects captured by the
model. Finally, while we use logistic regression models here, other
methods for risk prediction may be used. For example, survival
analysis, neural networks, or Poisson regression.

year old with diabetes and no other major risk factors might not
have a high short term risk of an ischemic stroke, their long term
risk might be higher. Understanding how the importance of risk
factors change with age may be essential in lowering the overall
burden of stroke on society.
Future work can be done to add in additional features, for
example lifestyle factors such as exercise levels or community
involvement. These risk factors may help to identify those who
are more at risk for a stroke in the short term and are factors that
are likely to change in importance with age. Additionally, in this
paper we focus on if differences occur between the distributions
of risk factors by age group and how those differences impact
modeling. We do not do an in depth analysis of the impact of
individual risk factors by age or research into why one risk factor
might be more important in one age group over another. Future
work can focus on a more in depth explanation of risk factors
according to age to better understand why we see the variations
found in this work.
Some of the limitations of the study include that the models
presented here predict short term risk, within 5 years, of an
ischemic stroke. However, while still important for those with a
high short term risk, long term risk, especially for the younger
population with generally low short term risk, might be more
informative. In predicting longer term risk the age models may
prove more important in identifying those features that might
not contribute highly to stroke risk when under a given age
but become more important as an individual ages. Additionally
we have the potential of looking at different time windows for
different age groups. For example, in the less than 50s, 10 or 20
year risk might be a more useful time frame, whereas it might
be more important to predict the 5 year risk for the 70 plus
age group. Predicting risk by age group allows us to look at
different time horizons for different age groups. The statistical
analysis and the creation of the models were all done using
data from the Framingham Heart Study. While we believe that
the non-proportionality of risk factors by age found here is
likely to apply to other populations, it might be necessary to
analyze other populations to determine that the patterns found
here are not a characteristics of the specific population. Other
populations might have different distributions of risk factors that
could impact the proportionality or non-proportionality of those
risk factors by age. It might be necessary to re-calibrate the model
to another population’s data to get the best risk predictions for
individual’s in a new population. Further while creating separate
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